ASX
Paradigm Biopharmaceuticals
PAR:ASX•Healthcare
Sensitive ASX Announcement
iPPS Phase 2 Biomarker Results Published in Leading Journal
Published: 28/01/26, 12:10pm (AEST)•5 pages